News & Articles
Latest news and informative articlesNews
Data Silos, Demos, Discussions at PhUSE
The latest papers and presentations from PhUSE US Connect in Baltimore and our future events, including CDISC.
Brexit, EMA, FDA & Global Regulatory News
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
PhUSE Keynote – A Cautionary Tale
A fascinating talk by the Keynote Speaker, Dr Ahadpour from the FDA on the opioid addiction crisis in the USA.
Regulatory Affairs & Quality Assurance: Copenhagen
Jakob Sandersen reports on the exciting developments at Pharmaceutical Services ApS over the last 15 months.
PhUSE US Connect & CDISC
Learn all about our presentations at PhUSE US Connect in Baltimore and at the CDISC Interchange in Amsterdam
SME Day at EMA – Part 3
The final report from Larissa Gould on the SME Day at EMA focuses on the Committee for Advanced Therapies, new Medical Devices Regulation and a Brexit update.
Qlik Specialization Status Awarded to S-cubed
Our Qlik Team are proud to announce that they have been awarded Pharmaceutical and Biotech Specialization status.
SME Day at the EMA – Part Two
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
SME Day at the EMA – Part One
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.
Brexit Update, Clinical Trial Data Sharing, & more
Our latest industry update covers news about Brexit, from FDA, EMA and more.
Qlik Team on Tour – Are you part of the Data Revolution?
Our Qlik Team are on Tour in Stockholm. Be part of the Data Revolution and join them there!
EMA, PhUSE, Bioforward and the latest Staff Update
Our staff and events teams are working hard, as we head towards the end of the year.
PhUSE Connect and future CDISC Training at S-cubed
We look forward to seeing you at PhUSE or our CDISC Public training in November.
The Impact of Brexit on Pharmaceuticals in the UK – UPDATE
Stephen Thompson, our regulatory affairs Director, writes about the latest Brexit news.
Brexit, access to medicines, data & data sharing
Our latest update from the industry reflects the ongoing uncertainty around BREXIT.
S-cubed: Building a Unique Culture
Here at S-cubed, we work hard but we know how to have some fun too!
The Impact of BREXIT on Pharmaceuticals in the UK
The UK government has now published its Policy Paper on “The future relationship between the United Kingdom and the European Union”.
Six months to go! Will you be ready for Serialisation by February 2019?
Harmonised European legislative measures come into force on 9th February 2019
BREXIT, PATIENT PERSPECTIVES, DATA SHARING in our Industry Insights for Q2
Our latest update from the industry demonstrates the uncertainty around BREXIT.
S-cubed on the road to success!
We were very proud to be part of the first PhUSE US Connect in Raleigh, North Carolina
S-cubed Presenting at PhUSE US Connect in RTP
We are delighted to be taking part in the inaugural PhUSE conference in the USA 3rd – 6th June 2018
Articles
Qlik: S-cubed Commenting Extension
Bohua Li introduces an S-cubed extension for adding user comments in a Qlik Sense application, along with a guide for users to implement the extension themselves.
Regulatory Affairs: An overview of PRIME, Breakthrough Therapy & Fast Track procedures
This article provides an overview of PRIME, Breakthrough Therapy and Fast Track regulatory procedures intended to optimise the development of medicines that target an unmet medical need.
Optimising the path to commercialisation; Who can help and when?
Regulatory Affairs Expert Tony Mitchell co-authors a case study for a new IBS Drug This is case study for a joint project S-cubed worked on for a new drug for IBS – PharmaVentures was the lead company and they were providing market valuation expertise, Apex Healthcare...
INDUSTRY INSIGHTS
Sign up to receive our Industry Insights every quarter
Sign up for our newsletter
Download our latest publication
- Brexit
- UK – Fast Track to Ground Breaking Medicines
- US Real Word Data
- Policies Consultations and Guidelines